Upgrade to SI Premium - Free Trial

Medpace (MEDP) PT Raised to $35.50 at Jefferies; Reiterates Hold

February 28, 2017 9:26 AM
Jefferies raised its price target on Medpace (NASDAQ: MEDP) to $35.50 (from $34.00) while maintaining a Hold rating. Guidance targets ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles